Fumonisin
Fumonisin
Fumonisins are a group of mycotoxins produced by several species of Fusarium, a type of filamentous fungi. These toxins are primarily found in maize (corn) and maize-based products. Fumonisins are known to cause a variety of health issues in both humans and animals, and they are a significant concern in food safety.
Chemical Structure
Fumonisins are characterized by their long-chain hydrocarbon structure. The most studied and prevalent fumonisin is Fumonisin B1, which is depicted in the image to the right. Fumonisin B1 consists of a 20-carbon backbone with two tricarballylic acid groups and an amine group, which contribute to its biological activity.
Biological Effects
Fumonisins interfere with the metabolism of sphingolipids, which are essential components of cell membranes. This interference can lead to a disruption in cell signaling and cell growth. In animals, fumonisins have been linked to diseases such as equine leukoencephalomalacia in horses and porcine pulmonary edema in pigs.
In humans, there is evidence suggesting that fumonisins may be associated with an increased risk of esophageal cancer and neural tube defects in populations consuming large amounts of contaminated maize.
Sources and Occurrence
Fumonisins are primarily produced by the Fusarium verticillioides and Fusarium proliferatum species. These fungi thrive in warm and humid conditions, which are conducive to the growth of maize. As a result, fumonisin contamination is more prevalent in regions with such climates.
Prevention and Control
To reduce the risk of fumonisin contamination, several strategies can be employed:
- Agricultural Practices: Implementing crop rotation and using resistant maize varieties can help reduce fungal growth.
- Storage Conditions: Proper drying and storage of maize can prevent fungal proliferation.
- Regulatory Measures: Many countries have established maximum allowable levels of fumonisins in food and feed to protect public health.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD